Avalon Investment & Advisory’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $585K | Sell |
66,293
-8,362
| -11% | -$73.8K | 0.02% | 238 |
|
|
2022
Q4 | $570K | Buy |
74,655
+11,954
| +19% | +$91.3K | 0.02% | 243 |
|
|
2022
Q3 | $446K | Buy |
62,701
+19,032
| +44% | +$135K | 0.01% | 238 |
|
|
2022
Q2 | $353K | Buy |
43,669
+20,257
| +87% | +$164K | 0.01% | 254 |
|
|
2022
Q1 | $325K | Buy |
23,412
+7,370
| +46% | +$102K | 0.01% | 276 |
|
|
2021
Q4 | $450K | Sell |
16,042
-10,879
| -40% | -$305K | 0.01% | 255 |
|
|
2021
Q3 | $915K | Buy |
26,921
+407
| +2% | +$13.8K | 0.02% | 246 |
|
|
2021
Q2 | $1.08M | Buy |
26,514
+5,931
| +29% | +$242K | 0.02% | 234 |
|
|
2021
Q1 | $829K | Buy |
20,583
+4,059
| +25% | +$163K | 0.02% | 254 |
|
|
2020
Q4 | $977K | Buy |
16,524
+4,787
| +41% | +$283K | 0.02% | 248 |
|
|
2020
Q3 | $571K | Buy |
+11,737
| New | +$571K | 0.01% | 257 |
|